Different mutations in the same cancer gene affected treatment response. Type 2 EGFR inhibitors may be more effective against glioblastoma. CHICAGO — The epidermal growth factor receptor mutations that occur in glioblastoma differ from those that...
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Discovery, meeting, Glioblastoma, EGFR, 2012 Annual Meeting, Annual Meeting, AACR Annual Meeting 2012, mutation, Ingo K. Mellinghoff